Articles by David A. Edmonson
20 On the Upswing: A Retrospective Cohort Study Evaluating Neoadjuvant Chemotherapy Response in Metaplastic Breast Cancer Patients
ByJessica F. Moore,Victoria Tiedemann,Julia Rozenberg,I. Angeles,Kamaljeet Singh,Stephanie Ng,Ashley R. Stuckey,Micaela A. Weaver,Jennifer Gass,William M. Sikov, MD,David A. Edmonson In 21 patients with metaplastic breast cancer receiving neoadjuvant chemotherapy, 48% achieved pCR—higher than prior estimates—with all pCR patients alive and disease-free at follow-up, suggesting modern regimens including pembrolizumab may improve outcomes in this chemoresistant subtype.
22 Implications of SOUND Trial on Adjuvant Radiation Therapy in Early Stage Breast Cancer Patients
ByJulia Rozenberg,S. Eskander,T. Nevill,Victoria Tiedemann,Jessica F. Moore,Stephanie Ng,Ashley R. Stuckey,Micaela A. Weaver,David A. Edmonson,Jaroslaw Hepel,Jennifer Gass In this institutional retrospective review, 14.4% of clinically node-negative patients meeting SOUND trial criteria had nodal metastases on SLNB, underscoring the need for careful multidisciplinary decision-making before integrating axillary staging de-escalation into practice.
